(Q50228698)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Effect of ezetimibe plus pravastatin on endothelial dysfunction in patients with systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

María del Pilar Cruz-Dominguez

9 March 2020

author

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

O Vera-Lastra

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

S Méndez-Flores

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

G Medina

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

E Calderón-Aranda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

L J Jara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

27 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

741-748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Endothelial function is associated with myocardial diastolic function in women with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Effect of high-dose statin versus low-dose statin plus ezetimibe on endothelial function: a meta-analysis of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Dual inhibition, newer paradigms for cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Endothelial dysfunction: the first step toward coronary arteriosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Impaired endothelial function in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

New advances in lipid-modifying therapies for reducing cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Ezetimibe, a selective inhibitor of the transport of cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

ACAT inhibitors: the search for novel cholesterol lowering agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Simvastatin with or without ezetimibe in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Accelerated atherosclerosis in autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203316631631

21 January 2018

Identifiers

DOI

10.1177/0961203316631631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26923285%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference